Clinical study of Apatinib combined with docetaxel as second-line treatment in advanced gastric cancer
Latest Information Update: 08 Oct 2020
At a glance
- Drugs Docetaxel (Primary) ; Rivoceranib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress
- 05 Jun 2018 Status changed from recruiting to completed, according to the results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology